PCSK9 levels do not predict severity and recurrence of cardiovascular events in patients with acute myocardial infarction.
Fiche publication
Date publication
novembre 2020
Journal
Nutrition, metabolism, and cardiovascular diseases : NMCD
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COTTIN Yves, Pr VERGELY Catherine
Tous les auteurs :
Zeller M, Lambert G, Farnier M, Maza M, Nativel B, Rochette L, Vergely C, Cottin Y
Lien Pubmed
Résumé
It remains unclear whether serum PCSK9 levels can predict the severity of the disease and the risk of future events in patients with coronary artery disease (CAD). We aimed to evaluate the association between PCSK9 levels, metabolic parameters, severity of CAD on coronary angiography (SYNTAX score), and the risk of in-hospital events and at one-year follow-up.
Mots clés
Acute myocardial infarction, Cohort studies, Hypercholesterolemia, PCSK9, Prognosis
Référence
Nutr Metab Cardiovasc Dis. 2020 Nov 20;: